Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722318 · ClinicalTrials.gov registry record · Phase 2
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 428
- Enrollment target
NCT01722318 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 428 participants.
The verdict
NCT01722318, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 428 participants
- Enrollment target
Study Summary
This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
Interventions
- DRUG Placebo
- DRUG Plecanatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01722318
The ClinicalTrials.gov registry entry for NCT01722318 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 428 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01722318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01722318 about?
NCT01722318 is a clinical study titled "The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)". This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
What is the current status of trial NCT01722318?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 428 participants. The study started on 2012-11. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01722318?
The interventions under investigation include: Placebo (DRUG), Plecanatide (DRUG).
Who is sponsoring clinical trial NCT01722318?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.